International Patent: CEACAM5-ANTIGEN-TARGETING ANTIBODY, ANTIBODY-DRUG CONJUGATE THEREOF AND USE THEREOF

GENEVA, June 19 -- INNOVENT BIOPHARMACEUTICALS (HANGZHOU) CO., LTD. filed a patent application (CN2025/134399) for “CEACAM5-ANTIGEN-TARGETING ANTIBODY, ANTIBODY-DRUG CONJUGATE THEREOF AND USE THEREOF”. With publication no. WO/2026/103740, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 47/68

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....